Market Overview

Cowen Initiates Synta Pharmaceuticals At Outperform


Cowen initiated coverage on Synta Pharmaceuticals Corp (NASDAQ: SNTA) with a Outperform rating.

Latest Ratings for SNTA

Oct 2015DowngradesBuyNeutral
Apr 2015Initiates Coverage onOutperform
Apr 2015Initiates Coverage onOutperform

View More Analyst Ratings for SNTA
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityInitiation Analyst Ratings


Related Articles (SNTA)

View Comments and Join the Discussion!

Latest Ratings

TORCCantor FitzgeraldDowngrades3.0
CIDMCanaccord GenuityMaintains1.5
TDGCanaccord GenuityMaintains620.0
DLPNCanaccord GenuityMaintains1.6
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Morgan Stanley Says General Electric Deal Is Equity-Friendly, Remains Bullish

Raymond James Initiates STORE Capital With Outperform